Korean Air anticipates uncertainties in the business environment this year due to shifts in the global political landscape, ...

Robert VanHimbergen; Chief Financial Officer, Senior Vice President; Hillenbrand Inc ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

The North Asian private equity giant cited rising demand for semiconductor products amid the AI boom for its decision to ...

Supporters of the move believe USAID was poorly managed and wasting taxpayers' money, with White House Press Secretary ...

Moderating job growth, rising inflation expectations and the prospect of reciprocal tariffs knocked the wind out of Wall ...